Clinical Trials Directory

Trials / Completed

CompletedNCT05141383

Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid Biopsy (HOPE)

Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid Biopsy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Institut Curie · Academic / Other
Sex
Male
Age
50 Years – 70 Years
Healthy volunteers
Accepted

Summary

Constitution of a biological collection within the framework of the establishment of a diagnostic, prognostic and active surveillance test for prostate cancer from long non-coding RNA biomarkers, in 3 cohorts of patients, with cancer of the prostate, with suspected cancer without biopsy confirmation or with prostatic hyperplasia and healthy donors. This biological collection will also be used as a support for further researches on the identification of biomarkers and genetic markers to improve the prognosis and diagnostic management of patients with prostate pathologies.

Detailed description

Multicenter, RIPH 2 study, evaluating on 3 patient cohorts the feasibility of setting up a diagnostic test, prognosis and active surveillance of prostate cancer using long non-coding RNA biomarkers. For patients agreeing to participate in the study and having signed a consent form, during their routine care consultation in the urology department, will have a blood sample and a urine sample after prostate massage as part of the study, and if necessary, a tissue sample as part of the treatment. Patients with prostate cancer will be followed as part of their care at least annually, and their follow-up data will be collected as part of the study, without additional sampling. A blood sample and a urine sample after prostate massage will be carried out during a single consultation at the CIC Henri Mondor for

Conditions

Interventions

TypeNameDescription
OTHERUrine samplingA blood sample and a urine sample after prostate massage will be carried out at baseline

Timeline

Start date
2022-05-04
Primary completion
2024-09-03
Completion
2024-09-03
First posted
2021-12-02
Last updated
2025-09-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05141383. Inclusion in this directory is not an endorsement.